Search results
Results from the WOW.Com Content Network
Scientists fear a potential COVID-19 vaccine could leave out a vulnerable population as it may be less effective for obese people. Obesity could hinder COVID-19 vaccine effectiveness, experts say ...
People classified as overweight are often hit more by loneliness. Addressing the problem of social isolation reduces the risk of mortality associated with obesity, a new study has found.
One way to estimate COVID-19 deaths that includes unconfirmed cases is to use the excess mortality, which is the overall number of deaths that exceed what would normally be expected. [4] From March 1, 2020, through the end of 2020, there were 522,368 excess deaths in the United States, or 22.9% more deaths than would have been expected in that ...
Global excess and reported COVID-19 deaths and death rates per 100,000 population according to the WHO study [12] A December 2022 WHO study comprehensively estimated excess deaths from the pandemic during 2020 and 2021, concluding ~14.8 million excess early deaths occurred, reaffirming their prior calculations from May as well as updating them ...
There is no evidence that mRNA Covid vaccines cause fatal cardiac arrest or other deadly heart problems in teens and young adults, a CDC report finds. Covid vaccines not linked to sudden death in ...
A universal coronavirus vaccine, also known as a pan-coronavirus vaccine, is a theoretical coronavirus vaccine that would be effective against all coronavirus strains. A universal vaccine would provide protection against coronavirus strains that have caused disease in humans, such as SARS-CoV-2 (including all its variants), while also providing ...
For the Netherlands, based on overall excess mortality, an estimated 20,000 people died from COVID-19 in 2020, [10] while only the death of 11,525 identified COVID-19 cases was registered. [9] The official count of COVID-19 deaths as of December 2021 is slightly more than 5.4 million, according to World Health Organization's report in May 2022 ...
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing.